Contact person

Susanne Wolfenstetter

Head of Sales & Customer Service SEND E-MAIL

Category

Antibodies/Antigens
Corona
COVID
COVID-19
SARS
SARS-CoV-2
Virus

Keywords

corona virus
SARS-CoV-2 Antigens

SARS-CoV-2 Antigens

InVivo BioTech Services GmbH

In order to mitigate the rising need for in vitro diagnostics in the global COVID-19 scenario, InVivo now offers diverse SARS-CoV-2 proteins in large-scale quantities, which are suitable for the development of highly sensitive IVD kits. Using InVivo’s proprietary manufacturing platforms, different recombinant versions of the viral Spike protein have been transiently expressed in high yielding mammalian HEK cells. These include the two functional units, S1 and S2, and the Receptor Binding Domain (RBD) of the S1 subunit that directly engages with host cells via the human receptor Angiotensin Converting Enzyme 2 (ACE2). To cater to larger demand of long-term bulk quantities in the gram scale, InVivo has also initiated development of several stable CHO cell lines.

Advantages of the product

  • Made in Germany

Downloads

Product Information S1-RBD_HEK Product Information S1-RBD_CHO Product Information Soluble Spike

Similar products

Contract Manufacturing, monoclonal antibodies, Proteins

Antibodies/Antigens, Substrates/Particles

Contract Manufacturing Monoclonal Antibodies, Native & Recombinant Proteins

Latex kits

Antibodies/Antigens, Immunochemistry, Indication

Febrile Antigen kits

Antibodies/Antigens, Indication